Arstasis CEO and leadership

Mr. Modesitt is a recognized leader in the femoral artery access and closure field, having been the primary inventor and designer of the Perclose Closer Device. In August 2004, Bruce incorporated Arstasis and transferred into it intellectual property rights for the self-sealing arteriotomy procedure he invented. From November 2011 to present Bruce has served as CTO of Arstasis. From August 2004 through November 2011, he recruited key employees, consultants, suppliers, directors, and investors for Arstasis, and managed the company to commercialization as its President and CEO. From 2003 to 2005, Bruce worked as an independent consultant to medical device manufacturers. From 2000 through 2003, he worked at Fogarty Research & Development where, working with Dr. Fogarty, he developed medical devices for vein harvesting, vein stripping, side branch management, remote endarterectomy, abdominal aortic aneurysm repair, thoracic aortic aneurysm repair and percutaneous heart valve repair. From 1997 through 2000, Bruce worked at Perclose, where he invented the Closer, which caused Abbott Labs to acquire Perclose for $680 million in 1998. From 1995 through 1997, he worked as an engineer at Progressive Angioplasty Systems (PAS). At PAS, Bruce was the primary inventor and designer of the Paragon™ coronary stent. PAS was sold to US Surgical in August of 1997 for $150 million, primarily because of the Paragon stent. The Paragon stent design remains the basis of many stents on the market today. Bruce holds over thirty US patents in the medical device field. Bruce was awarded a B.S.M.E. degree from Arizona State University in 1982.

David Bruce is a President/CEO at Arstasis Inc, President/CEO at IRIDEX CORP, and Manager at Arstasis Inc and is based in Danville, California. He has worked as President/CEO at Patient Safety Technologies, Board Member at Arstasis Inc, and Board Member at EP MEDSYSTEMS INC. David studied at Wharton School of the University of Pennsylvania, University of California Berkeley, and U C Berkeley.

Mr. Modesitt is a recognized leader in the femoral artery access and closure field, having been the primary inventor and designer of the Perclose Closer Device. In August 2004, Bruce incorporated Arstasis and transferred into it intellectual property rights for the self-sealing arteriotomy procedure he invented. From November 2011 to present Bruce has served as CTO of Arstasis. From August 2004 through November 2011, he recruited key employees, consultants, suppliers, directors, and investors for Arstasis, and managed the company to commercialization as its President and CEO. From 2003 to 2005, Bruce worked as an independent consultant to medical device manufacturers. From 2000 through 2003, he worked at Fogarty Research & Development where, working with Dr. Fogarty, he developed medical devices for vein harvesting, vein stripping, side branch management, remote endarterectomy, abdominal aortic aneurysm repair, thoracic aortic aneurysm repair and percutaneous heart valve repair. From 1997 through 2000, Bruce worked at Perclose, where he invented the Closer, which caused Abbott Labs to acquire Perclose for $680 million in 1998. From 1995 through 1997, he worked as an engineer at Progressive Angioplasty Systems (PAS). At PAS, Bruce was the primary inventor and designer of the Paragon™ coronary stent. PAS was sold to US Surgical in August of 1997 for $150 million, primarily because of the Paragon stent. The Paragon stent design remains the basis of many stents on the market today. Bruce holds over thirty US patents in the medical device field. Bruce was awarded a B.S.M.E. degree from Arizona State University in 1982.

Mr. Modesitt is a recognized leader in the femoral artery access and closure field, having been the primary inventor and designer of the Perclose Closer Device. In August 2004, Bruce incorporated Arstasis and transferred into it intellectual property rights for the self-sealing arteriotomy procedure he invented. From November 2011 to present Bruce has served as CTO of Arstasis. From August 2004 through November 2011, he recruited key employees, consultants, suppliers, directors, and investors for Arstasis, and managed the company to commercialization as its President and CEO. From 2003 to 2005, Bruce worked as an independent consultant to medical device manufacturers. From 2000 through 2003, he worked at Fogarty Research & Development where, working with Dr. Fogarty, he developed medical devices for vein harvesting, vein stripping, side branch management, remote endarterectomy, abdominal aortic aneurysm repair, thoracic aortic aneurysm repair and percutaneous heart valve repair. From 1997 through 2000, Bruce worked at Perclose, where he invented the Closer, which caused Abbott Labs to acquire Perclose for $680 million in 1998. From 1995 through 1997, he worked as an engineer at Progressive Angioplasty Systems (PAS). At PAS, Bruce was the primary inventor and designer of the Paragon™ coronary stent. PAS was sold to US Surgical in August of 1997 for $150 million, primarily because of the Paragon stent. The Paragon stent design remains the basis of many stents on the market today. Bruce holds over thirty US patents in the medical device field. Bruce was awarded a B.S.M.E. degree from Arizona State University in 1982.